Cargando…
A double blind, placebo-controlled randomized comparative study on the efficacy of phytosterol-enriched and conventional saw palmetto oil in mitigating benign prostate hyperplasia and androgen deficiency
BACKGROUND: The present clinical trial was conducted to evaluate the efficacy and tolerability of a standardized saw palmetto oil containing 3% β-sitosterol in the treatment of benign prostate hyperplasia (BPH) and androgen deficiency. METHODS: Subjects aged 40–65 years with symptomatic BPH were ran...
Autores principales: | Sudeep, H. V., Thomas, Jestin V., Shyamprasad, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333342/ https://www.ncbi.nlm.nih.gov/pubmed/32620155 http://dx.doi.org/10.1186/s12894-020-00648-9 |
Ejemplares similares
-
A phytosterol-enriched saw palmetto supercritical CO(2) extract ameliorates testosterone-induced benign prostatic hyperplasia by regulating the inflammatory and apoptotic proteins in a rat model
por: Sudeep, Heggar V., et al.
Publicado: (2019) -
Fatty Acid and Phytosterol Content of Commercial Saw Palmetto Supplements
por: Penugonda, Kavitha, et al.
Publicado: (2013) -
Oral and Topical Administration of a Standardized Saw Palmetto Oil Reduces Hair Fall and Improves the Hair Growth in Androgenetic Alopecia Subjects – A 16-Week Randomized, Placebo-Controlled Study
por: Sudeep, Heggar Venkataramana, et al.
Publicado: (2023) -
Saw Palmetto
Publicado: (1898) -
Saw Palmetto
Publicado: (1912)